Bruker EVP exercises options, sells 2,000 shares
Bruker Corp executive Mark Munch exercised stock options and sold shares in a planned transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Bruker Corp executive Mark Munch exercised stock options and sold shares in a planned transaction. He exercised options for 2,000 shares of common stock at $22.19 per share and then sold 2,000 shares at $39.90 per share on the same date.
After these transactions, he directly owns 128,443 shares of Bruker common stock. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Purchase) | 2,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,000 | $22.19 | $44K |
| Sale | Common Stock | 2,000 | $39.90 | $80K |
Footnotes (2)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2. The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Stock Option (Right to Purchase) financial
Exercise or conversion of derivative security financial
open-market sale financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BRKR executive Mark Munch report?
Were Mark Munch’s BRKR stock sales made under a Rule 10b5-1 plan?
What options did Mark Munch exercise in this BRKR Form 4?
Is the BRKR insider transaction primarily a buy or a sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.